AMPH
Price
$24.16
Change
+$0.64 (+2.72%)
Updated
Apr 11 closing price
Capitalization
2.11B
25 days until earnings call
EOLS
Price
$9.54
Change
+$0.13 (+1.38%)
Updated
Apr 11 closing price
Capitalization
846.82M
31 days until earnings call
Ad is loading...

AMPH vs EOLS

Header iconAMPH vs EOLS Comparison
Open Charts AMPH vs EOLSBanner chart's image
Amphastar Pharmaceuticals
Price$24.16
Change+$0.64 (+2.72%)
Volume$482.79K
Capitalization2.11B
Evolus
Price$9.54
Change+$0.13 (+1.38%)
Volume$1.12M
Capitalization846.82M
AMPH vs EOLS Comparison Chart
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. EOLS commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Hold and EOLS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 12, 2025
Stock price -- (AMPH: $24.16 vs. EOLS: $9.54)
Brand notoriety: AMPH and EOLS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMPH: 75% vs. EOLS: 141%
Market capitalization -- AMPH: $2.11B vs. EOLS: $846.82M
AMPH [@Pharmaceuticals: Other] is valued at $2.11B. EOLS’s [@Pharmaceuticals: Other] market capitalization is $846.82M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whileEOLS’s FA Score has 0 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • EOLS’s FA Score: 0 green, 5 red.
According to our system of comparison, AMPH is a better buy in the long-term than EOLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 4 TA indicator(s) are bullish while EOLS’s TA Score has 4 bullish TA indicator(s).

  • AMPH’s TA Score: 4 bullish, 4 bearish.
  • EOLS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AMPH is a better buy in the short-term than EOLS.

Price Growth

AMPH (@Pharmaceuticals: Other) experienced а -9.21% price change this week, while EOLS (@Pharmaceuticals: Other) price change was -10.76% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.37%. For the same industry, the average monthly price growth was -3.00%, and the average quarterly price growth was -12.91%.

Reported Earning Dates

AMPH is expected to report earnings on Aug 11, 2025.

EOLS is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.37% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMPH($2.11B) has a higher market cap than EOLS($847M). EOLS YTD gains are higher at: -13.587 vs. AMPH (-34.931). AMPH has higher annual earnings (EBITDA): 240M vs. EOLS (-41.81M). AMPH has more cash in the bank: 257M vs. EOLS (62.8M). EOLS has less debt than AMPH: EOLS (127M) vs AMPH (624M). AMPH has higher revenues than EOLS: AMPH (644M) vs EOLS (202M).
AMPHEOLSAMPH / EOLS
Capitalization2.11B847M249%
EBITDA240M-41.81M-574%
Gain YTD-34.931-13.587257%
P/E Ratio16.69N/A-
Revenue644M202M319%
Total Cash257M62.8M409%
Total Debt624M127M491%
FUNDAMENTALS RATINGS
AMPH vs EOLS: Fundamental Ratings
AMPH
EOLS
OUTLOOK RATING
1..100
6955
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
93
Overvalued
PROFIT vs RISK RATING
1..100
7157
SMR RATING
1..100
4099
PRICE GROWTH RATING
1..100
8985
P/E GROWTH RATING
1..100
92100
SEASONALITY SCORE
1..100
506

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMPH's Valuation (64) in the Pharmaceuticals Other industry is in the same range as EOLS (93) in the Pharmaceuticals Major industry. This means that AMPH’s stock grew similarly to EOLS’s over the last 12 months.

EOLS's Profit vs Risk Rating (57) in the Pharmaceuticals Major industry is in the same range as AMPH (71) in the Pharmaceuticals Other industry. This means that EOLS’s stock grew similarly to AMPH’s over the last 12 months.

AMPH's SMR Rating (40) in the Pharmaceuticals Other industry is somewhat better than the same rating for EOLS (99) in the Pharmaceuticals Major industry. This means that AMPH’s stock grew somewhat faster than EOLS’s over the last 12 months.

EOLS's Price Growth Rating (85) in the Pharmaceuticals Major industry is in the same range as AMPH (89) in the Pharmaceuticals Other industry. This means that EOLS’s stock grew similarly to AMPH’s over the last 12 months.

AMPH's P/E Growth Rating (92) in the Pharmaceuticals Other industry is in the same range as EOLS (100) in the Pharmaceuticals Major industry. This means that AMPH’s stock grew similarly to EOLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHEOLS
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 20 days ago
74%
Bullish Trend 27 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
68%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OCRDX16.97N/A
N/A
Invesco Rising Dividends C
PRLAX17.18N/A
N/A
T. Rowe Price Latin America
EAGCX17.12N/A
N/A
Eaton Vance Atlanta Capital Focused Gr C
LFGTX30.93N/A
N/A
Lord Abbett Focused Growth R5
DOXFX50.78N/A
N/A
Dodge & Cox International Stock X

AMPH and

Correlation & Price change

A.I.dvisor tells us that AMPH and COLL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMPH and COLL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
+2.72%
COLL - AMPH
31%
Poorly correlated
+6.61%
ALKS - AMPH
30%
Poorly correlated
+1.54%
DVAX - AMPH
28%
Poorly correlated
+2.55%
SUPN - AMPH
26%
Poorly correlated
+1.93%
AMRX - AMPH
26%
Poorly correlated
+0.14%
More

EOLS and

Correlation & Price change

A.I.dvisor tells us that EOLS and AQST have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EOLS and AQST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EOLS
1D Price
Change %
EOLS100%
+1.33%
AQST - EOLS
30%
Poorly correlated
+2.07%
NBIX - EOLS
29%
Poorly correlated
+0.17%
RDHL - EOLS
29%
Poorly correlated
-13.31%
AMPH - EOLS
29%
Poorly correlated
+2.72%
ALKS - EOLS
29%
Poorly correlated
+1.54%
More